Bibliometric Analysis
Journal Bibliometric Report (2021)
The Journal Bibliometric Report is based on all publications in Medline/Pubmed that were cited by Medline/Pubmed publications in 2021.
Journals for Psychopharmacology
For each journal, the table below lists the year of the most recent citable publication (Last Year); the total number of times citable publications were cited in 2021 (Total Cites); the average number of times citable publications from 2019 and 2020 were cited by publications in 2021 (Impact Factor); the average number of times citable publications from 2016 through 2020 were cited by publications in 2021 (5-Year Impact); the average number of times citable publications from 2021 were cited by publications in 2021 (Immediacy Index); the number of citable publications in 2021 (Articles); and the median age in years of citable publications that were cited by publications in 2021 (Cited Half-Life). Citable publications are those whose Medline/Pubmed type is "Journal Article", which in general includes things like original research, meta-analysis, and reviews, but does not include editorials or letters. The data in the table below includes self-citations.
| Rank | Journal | Last Year | Total Cites | Impact Factor | 5-Year Impact | Immediacy Index | Articles | CitedHalfLife | JournalDetails |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Adv Biochem Psychopharmacol | 1995 | 50 | 0.000 | 0.000 | 0.000 | 0 | 41 | Details |
| 2 | Cannabis Cannabinoid Res | 2026 | 908 | 2.758 | 4.596 | 0.400 | 110 | 3 | Details |
| 3 | Clin Neuropharmacol | 2026 | 1181 | 0.594 | 0.716 | 0.063 | 63 | 12 | Details |
| 4 | Curr Dev Psychopharmacol | 1981 | 3 | 0.000 | 0.000 | 0.000 | 0 | 42 | Details |
| 5 | Essent Psychopharmacol | 2006 | 8 | 0.000 | 0.000 | 0.000 | 0 | 16 | Details |
| 6 | Eur Neuropsychopharmacol | 2026 | 5003 | 2.517 | 2.548 | 0.662 | 154 | 7 | Details |
| 7 | Exp Clin Psychopharmacol | 2026 | 1821 | 1.503 | 1.641 | 0.398 | 103 | 8 | Details |
| 8 | Harm Reduct J | 2026 | 1460 | 2.871 | 2.855 | 0.500 | 120 | 3 | Details |
| 9 | Hum Psychopharmacol | 2026 | 1171 | 0.961 | 1.214 | 0.362 | 47 | 9 | Details |
| 10 | Int Clin Psychopharmacol | 2026 | 1097 | 1.045 | 1.074 | 0.286 | 49 | 12 | Details |
| 11 | Int J Neuropsychopharmacol | 2026 | 4726 | 2.849 | 3.167 | 1.518 | 85 | 7 | Details |
| 12 | J Child Adolesc Psychopharmacol | 2026 | 1826 | 1.622 | 1.601 | 0.151 | 73 | 6 | Details |
| 13 | J Clin Psychopharmacol | 2026 | 2442 | 0.934 | 1.235 | 0.340 | 94 | 11 | Details |
| 14 | J Psychoactive Drugs | 2026 | 1428 | 1.787 | 1.558 | 0.319 | 72 | 9 | Details |
| 15 | J Psychopharmacol | 2026 | 4955 | 2.289 | 2.637 | 0.805 | 123 | 7 | Details |
| 16 | Mod Probl Pharmacopsychiatry | 1997 | 119 | 0.000 | 0.000 | 0.000 | 0 | 34 | Details |
| 17 | Mod Trends Pharmacopsychiatry | 2017 | 79 | 0.000 | 1.583 | 0.000 | 0 | 6 | Details |
| 18 | Neuropsychopharmacol Hung | 2026 | 58 | 0.265 | 0.198 | 0.059 | 17 | 9 | Details |
| 19 | Neuropsychopharmacol Rep | 2026 | 274 | 1.475 | 1.336 | 1.348 | 66 | 1 | Details |
| 20 | Neuropsychopharmacology | 2026 | 21023 | 4.156 | 4.728 | 0.954 | 260 | 8 | Details |
| 21 | Nihon Shinkei Seishin Yakurigaku Zasshi | 2017 | 45 | 0.000 | 0.231 | 0.000 | 0 | 13 | Details |
| 22 | Nord J Psychiatry | 2026 | 1344 | 0.860 | 1.075 | 0.141 | 99 | 8 | Details |
| 23 | Pharmacol Biochem Behav | 2026 | 7243 | 1.780 | 1.867 | 0.430 | 114 | 14 | Details |
| 24 | Pharmacopsychiatry | 2026 | 996 | 1.208 | 1.561 | 0.375 | 32 | 11 | Details |
| 25 | Prog Neuropsychopharmacol Biol Psychiatry | 2026 | 8278 | 2.592 | 2.761 | 1.052 | 193 | 7 | Details |
| 26 | Psychopharmacol Bull | 2026 | 873 | 0.586 | 0.832 | 0.424 | 33 | 30 | Details |
| 27 | Psychopharmacol Ser | 1993 | 7 | 0.000 | 0.000 | 0.000 | 0 | 33 | Details |
| 28 | Psychopharmacology (Berl) | 2026 | 15003 | 2.429 | 2.398 | 0.518 | 282 | 11 | Details |
| 29 | Psychopharmacology Suppl | 1985 | 3 | 0.000 | 0.000 | 0.000 | 0 | 37 | Details |
| 30 | Yakubutsu Seishin Kodo | 1993 | 7 | 0.000 | 0.000 | 0.000 | 0 | 31 | Details |